Meet Our Researchers
Anna Greka, an institute member of the Broad Institute of MIT and Harvard, is a practicing nephrologist and scientist who studies the basic molecular mechanisms of kidney disease in order to eventually develop targeted therapies. She is also an assistant professor at Harvard Medical School and an associate physician in the Renal Division at Brigham and Women’s Hospital.
Genetic kidney diseases are rare but devastating, with extremely limited treatment options. Because there are so few patients, each one can provide clues that can help improve therapy for all sufferers. Anna has identified a kidney disease patient who responds exceptionally well to a particular drug, and with BroadIgnite support, she’ll identify similar patients in order to understand why the drug is effective for them. Those results could improve the lives of many patients—from those with rare, genetic kidney diseases to the millions who have diabetic kidney disease.